These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 810194)
1. Mediators of passive lung anaphylaxis in the rat. Farmer JB; Richards IM; Sheard P; Woods AM Br J Pharmacol; 1975 Sep; 55(1):57-64. PubMed ID: 810194 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue. Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530 [TBL] [Abstract][Full Text] [Related]
3. The release of spasmogenic substances from human chopped lung tissue and its inhibition. Piper PJ; Walker JL Br J Pharmacol; 1973 Feb; 47(2):291-304. PubMed ID: 4352867 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies on the release of slow reacting substance of anaphylaxis during anti-immunoglobulin E antibody mediated passive peritoneal anaphylaxis in rats. Nagai H; Yamada H; Matsuura N; Iwamoto T; Choi SH; Koda A J Pharmacobiodyn; 1987 Jan; 10(1):49-54. PubMed ID: 3108486 [TBL] [Abstract][Full Text] [Related]
5. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis]. Terasawa M; Imayoshi T; Goto K Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):93-101. PubMed ID: 6194083 [TBL] [Abstract][Full Text] [Related]
6. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases. Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511 [TBL] [Abstract][Full Text] [Related]
7. Acute systemic anaphylaxis in the calf. Eyre P; Lewis AJ; Wells PW Br J Pharmacol; 1973 Mar; 47(3):504-16. PubMed ID: 4147191 [TBL] [Abstract][Full Text] [Related]
8. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine. Engineer DM; Niederhauser U; Piper PJ; Sirois P Br J Pharmacol; 1978 Jan; 62(1):61-6. PubMed ID: 74266 [TBL] [Abstract][Full Text] [Related]
9. The inhibition by dexamethasone and disodium cromoglycate of anaphylactic bronchoconstriction in the rat. Church MK; Collier HO; James GW Br J Pharmacol; 1972 Sep; 46(1):56-65. PubMed ID: 4404396 [TBL] [Abstract][Full Text] [Related]
10. The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition. Engineer DM; Morris HR; Piper PJ; Sirois P Br J Pharmacol; 1978 Oct; 64(2):211-8. PubMed ID: 708991 [TBL] [Abstract][Full Text] [Related]
11. Peritoneal anaphylaxis in the rat after sensitization with mouse antiserum. Spicer BA; Ross JW; Sharpe TJ; Smith H Int Arch Allergy Appl Immunol; 1978; 56(6):493-9. PubMed ID: 415988 [TBL] [Abstract][Full Text] [Related]
12. A novel model of IgE-mediated passive pulmonary anaphylaxis in rats. Wex E; Thaler E; Blum S; Lamb D PLoS One; 2014; 9(12):e116166. PubMed ID: 25541997 [TBL] [Abstract][Full Text] [Related]
13. The effect of sodium 5,6-dimethyl-2-nitroindanedione on anaphylactic reactions in vitro. Sharpe TJ; Ross JW; Spicer BA Agents Actions; 1978 Apr; 8(3):199-202. PubMed ID: 78665 [TBL] [Abstract][Full Text] [Related]
14. Rat passive peritoneal anaphylaxis following sensitisation with guinea pig antiserum: an immediate hypersensitivity reaction without histamine release. Smith H; Ross JW; Spicer BA Int Arch Allergy Appl Immunol; 1980; 62(2):195-204. PubMed ID: 6154654 [TBL] [Abstract][Full Text] [Related]
15. Increased vascular permeability during passive peritoneal anaphylaxis in the rat. The effects of disodium cromoglycate and a nitroindanedione. Ross JW; Smith H; Spicer BA Int Arch Allergy Appl Immunol; 1976; 51(2):226-37. PubMed ID: 58838 [TBL] [Abstract][Full Text] [Related]
16. Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis. Ohashi M; Uno T; Nishino K Int Arch Allergy Immunol; 1993; 101(3):288-96. PubMed ID: 8324390 [TBL] [Abstract][Full Text] [Related]
17. Response of rat lung to humoral mediators of anaphylaxis and its modification by drugs and sensitization. Church MK Br J Pharmacol; 1975 Nov; 55(3):423-30. PubMed ID: 1203628 [TBL] [Abstract][Full Text] [Related]
18. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological analysis of the vascular permeability response in the anaphylactic phase of allergic inflammation in rats. Ohuchi K; Hirasawa N; Watanabe M; Tsurufuji S Eur J Pharmacol; 1985 Nov; 117(3):337-45. PubMed ID: 4076349 [TBL] [Abstract][Full Text] [Related]
20. Relative bioactivity of histamine and slow reacting substance of anaphylaxis released during anaphylactic reaction from different tissues of guinea pigs and rats. Shahani SR; Dhar HL Indian J Physiol Pharmacol; 1987; 31(2):107-10. PubMed ID: 2444537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]